Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.

This study evaluates whether intrathecal MVIIA injection after spinal cord injury (SCI) elicits neuroprotective effects. The test rats were randomly distributed into six groups- sham, placebo, MVIIA 2.5 μM, MVIIA 5 μM, MVIIA 10 μM, and MVIIA 20 μM-and were administered the treatment four hours after...

Full description

Bibliographic Details
Main Authors: Karen M Oliveira, Nancy S Binda, Mário Sérgio L Lavor, Carla M O Silva, Isabel R Rosado, Endrigo L A Gabellini, Juliana F Da Silva, Camila M Oliveira, Marília M Melo, Marcus Vinícius Gomez, Eliane G Melo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6171875?pdf=render
_version_ 1818938932821229568
author Karen M Oliveira
Nancy S Binda
Mário Sérgio L Lavor
Carla M O Silva
Isabel R Rosado
Endrigo L A Gabellini
Juliana F Da Silva
Camila M Oliveira
Marília M Melo
Marcus Vinícius Gomez
Eliane G Melo
author_facet Karen M Oliveira
Nancy S Binda
Mário Sérgio L Lavor
Carla M O Silva
Isabel R Rosado
Endrigo L A Gabellini
Juliana F Da Silva
Camila M Oliveira
Marília M Melo
Marcus Vinícius Gomez
Eliane G Melo
author_sort Karen M Oliveira
collection DOAJ
description This study evaluates whether intrathecal MVIIA injection after spinal cord injury (SCI) elicits neuroprotective effects. The test rats were randomly distributed into six groups- sham, placebo, MVIIA 2.5 μM, MVIIA 5 μM, MVIIA 10 μM, and MVIIA 20 μM-and were administered the treatment four hours after SCI. After the optimal MVIIA dose (MVIIA 10 μM) was defined, the best time for application, one or four hours, was analyzed. Locomotor hind limb function and side effects were assessed. Forty-eight hours after the injury and immediately after euthanasia, spinal cord segments were removed from the test rats. Cell viability, reactive oxygen species, lipid peroxidation, and glutamate release were investigated. To examine the MVIIA mechanism of action, the gene expressions of pro-apoptotic (Bax, nNOS, and caspase-3, -8, -9, -12) and anti-apoptotic (Bcl-xl) factors in the spinal cord tissue samples were determined by real-time PCR, and the activities of antioxidant enzymes were also investigated. Application of intrathecal MVIIA 10 μM four hours after SCI prompted a neuroprotective effect: neuronal death decreased (22.46%), oxidative stress diminished, pro-apoptotic factors (Bax, nNOS, and caspase-3, -8) were expressed to a lesser extent, and mitochondrial viability as well as anti-apoptotic factor (Bcl-xl) expression increased. These results suggested that MVIIA provided neuroprotection through antioxidant effects. Indeed, superoxide dismutase (188.41%), and glutathione peroxidase (199.96%), reductase (193.86%), and transferase (175.93%) expressions increased. Therefore, intrathecal MVIIA (MVIIA 10 μM, 4 h) application has neuroprotective potential, and the possible mechanisms are related to antioxidant agent modulation and to intrinsic and extrinsic apoptotic pathways.
first_indexed 2024-12-20T06:15:43Z
format Article
id doaj.art-06344253c9f84a75b44ebc063f802fba
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T06:15:43Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-06344253c9f84a75b44ebc063f802fba2022-12-21T19:50:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011310e020494810.1371/journal.pone.0204948Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.Karen M OliveiraNancy S BindaMário Sérgio L LavorCarla M O SilvaIsabel R RosadoEndrigo L A GabelliniJuliana F Da SilvaCamila M OliveiraMarília M MeloMarcus Vinícius GomezEliane G MeloThis study evaluates whether intrathecal MVIIA injection after spinal cord injury (SCI) elicits neuroprotective effects. The test rats were randomly distributed into six groups- sham, placebo, MVIIA 2.5 μM, MVIIA 5 μM, MVIIA 10 μM, and MVIIA 20 μM-and were administered the treatment four hours after SCI. After the optimal MVIIA dose (MVIIA 10 μM) was defined, the best time for application, one or four hours, was analyzed. Locomotor hind limb function and side effects were assessed. Forty-eight hours after the injury and immediately after euthanasia, spinal cord segments were removed from the test rats. Cell viability, reactive oxygen species, lipid peroxidation, and glutamate release were investigated. To examine the MVIIA mechanism of action, the gene expressions of pro-apoptotic (Bax, nNOS, and caspase-3, -8, -9, -12) and anti-apoptotic (Bcl-xl) factors in the spinal cord tissue samples were determined by real-time PCR, and the activities of antioxidant enzymes were also investigated. Application of intrathecal MVIIA 10 μM four hours after SCI prompted a neuroprotective effect: neuronal death decreased (22.46%), oxidative stress diminished, pro-apoptotic factors (Bax, nNOS, and caspase-3, -8) were expressed to a lesser extent, and mitochondrial viability as well as anti-apoptotic factor (Bcl-xl) expression increased. These results suggested that MVIIA provided neuroprotection through antioxidant effects. Indeed, superoxide dismutase (188.41%), and glutathione peroxidase (199.96%), reductase (193.86%), and transferase (175.93%) expressions increased. Therefore, intrathecal MVIIA (MVIIA 10 μM, 4 h) application has neuroprotective potential, and the possible mechanisms are related to antioxidant agent modulation and to intrinsic and extrinsic apoptotic pathways.http://europepmc.org/articles/PMC6171875?pdf=render
spellingShingle Karen M Oliveira
Nancy S Binda
Mário Sérgio L Lavor
Carla M O Silva
Isabel R Rosado
Endrigo L A Gabellini
Juliana F Da Silva
Camila M Oliveira
Marília M Melo
Marcus Vinícius Gomez
Eliane G Melo
Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.
PLoS ONE
title Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.
title_full Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.
title_fullStr Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.
title_full_unstemmed Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.
title_short Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats.
title_sort conotoxin mviia improves cell viability and antioxidant system after spinal cord injury in rats
url http://europepmc.org/articles/PMC6171875?pdf=render
work_keys_str_mv AT karenmoliveira conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT nancysbinda conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT mariosergiollavor conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT carlamosilva conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT isabelrrosado conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT endrigolagabellini conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT julianafdasilva conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT camilamoliveira conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT mariliammelo conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT marcusviniciusgomez conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats
AT elianegmelo conotoxinmviiaimprovescellviabilityandantioxidantsystemafterspinalcordinjuryinrats